Veterans with PTSD to test High-THC cannabis in landmark trial
NCT ID NCT07224698
First seen Nov 05, 2025 · Last updated Jun 19, 2026 · Updated 25 times
Summary
This Phase 2 study will test whether inhaling high-THC cannabis (18-22% THC) can reduce PTSD symptoms in 320 U.S. veterans compared to a placebo with less than 1% THC. Participants will be randomly assigned to one of two groups in a double-blind design, and researchers will measure changes in PTSD severity and daily functioning over time. The goal is to provide reliable evidence on a treatment already widely used by veterans.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for POST TRAUMATIC STRESS DISORDER PTSD are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Scottsdale Research Institute
Cave Creek, Arizona, 85331, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
high-THC cannabis (dried flower with 18-22% THC)
What this could lead to
If it works, this could provide a controlled, evidence-based option for veterans to manage PTSD symptoms using inhaled cannabis.
What could go wrong
This is a Phase 2 trial, so results are still early. The placebo effect is strong in PTSD studies, and high-THC cannabis may cause side effects like anxiety or impaired cognition.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.